1. Home
  2. URI vs REGN Comparison

URI vs REGN Comparison

Compare URI & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Rentals Inc.

URI

United Rentals Inc.

HOLD

Current Price

$1,141.59

Market Cap

63.5B

ML Signal

HOLD

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$656.01

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
URI
REGN
Founded
1997
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.5B
68.8B
IPO Year
1998
1995

Fundamental Metrics

Financial Performance
Metric
URI
REGN
Price
$1,141.59
$656.01
Analyst Decision
Buy
Buy
Analyst Count
13
25
Target Price
$1,023.25
$830.16
AVG Volume (30 Days)
434.2K
724.5K
Earning Date
04-22-2026
04-29-2026
Dividend Yield
0.83%
0.55%
EPS Growth
N/A
8.19
EPS
8.43
6.75
Revenue
$16,099,000,000.00
$5,872,227,000.00
Revenue This Year
$7.01
$12.45
Revenue Next Year
$7.15
$10.13
P/E Ratio
$135.42
$97.19
Revenue Growth
4.91
20.82
52 Week Low
$701.59
$541.00
52 Week High
$1,177.67
$821.11

Technical Indicators

Market Signals
Indicator
URI
REGN
Relative Strength Index (RSI) 61.00 55.08
Support Level $780.54 $648.66
Resistance Level N/A $670.96
Average True Range (ATR) 33.84 14.60
MACD 4.73 -0.72
Stochastic Oscillator 77.41 51.44

Price Performance

Historical Comparison
URI
REGN

About URI United Rentals Inc.

United Rentals is the world's largest equipment rental company, principally operating in the US and Canada. It has 16% share in a highly fragmented market serving general industrial (49%), commercial construction (46%), and residential construction (5%). The company operates a $21 billion fleet of equipment, including aerial platforms, forklifts, excavators, trucks, power generators, and various other materials serving local and national accounts from nearly 1,600 locations in North America and 100 abroad. It has pursued a strategy of bundling specialty rental capabilities to offer its customers more advanced solutions in addition to its core equipment rental business, supporting its ambitions to become a one-stop shop for customers and enhance and maintain its margin profile.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: